These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9836060)

  • 1. Computational model of obsessive-compulsive disorder: examination of etiologic hypothesis and treatment strategies.
    Ownby RL
    Depress Anxiety; 1998; 8(3):91-103. PubMed ID: 9836060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurophysiologic dysfunction in basal ganglia/limbic striatal and thalamocortical circuits as a pathogenetic mechanism of obsessive-compulsive disorder.
    Modell JG; Mountz JM; Curtis GC; Greden JF
    J Neuropsychiatry Clin Neurosci; 1989; 1(1):27-36. PubMed ID: 2535426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neurobiology of obsessive-compulsive disorder].
    Karch S; Pogarell O
    Nervenarzt; 2011 Mar; 82(3):299-307. PubMed ID: 21424418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial neural network model for the prediction of obsessive-compulsive disorder treatment response.
    Salomoni G; Grassi M; Mosini P; Riva P; Cavedini P; Bellodi L
    J Clin Psychopharmacol; 2009 Aug; 29(4):343-9. PubMed ID: 19593173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition and treatment of obsessive-compulsive disorder.
    Goodman WK; Lydiard RB
    J Clin Psychiatry; 2007 Dec; 68(12):e30. PubMed ID: 18162010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obsessive-compulsive disorder.
    Bokor G; Anderson PD
    J Pharm Pract; 2014 Apr; 27(2):116-30. PubMed ID: 24576790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine transporter density in the basal ganglia in obsessive-compulsive disorder, measured with [123I]IPT SPECT before and after treatment with serotonin reuptake inhibitors.
    Kim CH; Cheon KA; Koo MS; Ryu YH; Lee JD; Chang JW; Lee HS
    Neuropsychobiology; 2007; 55(3-4):156-62. PubMed ID: 17657168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New approach to obsessive-compulsive disorder: dopaminergic theories].
    Harsányi A; Csigó K; Demeter G; Németh A
    Psychiatr Hung; 2007; 22(4):248-58. PubMed ID: 18167420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurobiological model of obsessive-compulsive disorder: evidence from recent neuropsychological and neuroimaging findings.
    Nakao T; Okada K; Kanba S
    Psychiatry Clin Neurosci; 2014 Aug; 68(8):587-605. PubMed ID: 24762196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential role for orbitofrontal serotonin 1B receptors in obsessive-compulsive disorder-like behavior and serotonin reuptake inhibitor response in mice.
    Shanahan NA; Velez LP; Masten VL; Dulawa SC
    Biol Psychiatry; 2011 Dec; 70(11):1039-48. PubMed ID: 21920503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased limbic and increased fronto-parietal connectivity in unmedicated patients with obsessive-compulsive disorder.
    Göttlich M; Krämer UM; Kordon A; Hohagen F; Zurowski B
    Hum Brain Mapp; 2014 Nov; 35(11):5617-32. PubMed ID: 25044747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered corticostriatal functional connectivity in obsessive-compulsive disorder.
    Harrison BJ; Soriano-Mas C; Pujol J; Ortiz H; López-Solà M; Hernández-Ribas R; Deus J; Alonso P; Yücel M; Pantelis C; Menchon JM; Cardoner N
    Arch Gen Psychiatry; 2009 Nov; 66(11):1189-200. PubMed ID: 19884607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obsessive-compulsive disorder.
    Goodman WK; Grice DE; Lapidus KA; Coffey BJ
    Psychiatr Clin North Am; 2014 Sep; 37(3):257-67. PubMed ID: 25150561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacological treatments for obsessive-compulsive disorder and the serotonin-dopamine hypothesis].
    Okamoto Y
    Seishin Shinkeigaku Zasshi; 2011; 113(1):36-44. PubMed ID: 21404630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional connectivity of the raphe nucleus as a predictor of the response to selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
    Kim M; Kwak S; Yoon YB; Kwak YB; Kim T; Cho KIK; Lee TY; Kwon JS
    Neuropsychopharmacology; 2019 Nov; 44(12):2073-2081. PubMed ID: 31189178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional disruption in prefrontal-striatal network in obsessive-compulsive disorder.
    Sha Z; Versace A; Edmiston EK; Fournier J; Graur S; Greenberg T; Santos JPL; Chase HW; Stiffler RS; Bonar L; Hudak R; Yendiki A; Greenberg BD; Rasmussen S; Liu H; Quirk G; Haber S; Phillips ML
    Psychiatry Res Neuroimaging; 2020 Jun; 300():111081. PubMed ID: 32344156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered anatomical connections of associative and limbic cortico-basal-ganglia circuits in obsessive-compulsive disorder.
    Haynes WIA; Clair AH; Fernandez-Vidal S; Gholipour B; Morgiève M; Mallet L
    Eur Psychiatry; 2018 Jun; 51():1-8. PubMed ID: 29514116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obsessive-compulsive behaviour: a disorder of decision-making.
    Sachdev PS; Malhi GS
    Aust N Z J Psychiatry; 2005 Sep; 39(9):757-63. PubMed ID: 16168033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DISSECTING OCD CIRCUITS: FROM ANIMAL MODELS TO TARGETED TREATMENTS.
    Ahmari SE; Dougherty DD
    Depress Anxiety; 2015 Aug; 32(8):550-62. PubMed ID: 25952989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain-behavior relationships in obsessive-compulsive disorder.
    Saxena S; Bota RG; Brody AL
    Semin Clin Neuropsychiatry; 2001 Apr; 6(2):82-101. PubMed ID: 11296309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.